Processa Pharmaceuticals Inc (NAS:PCSA)
$ 1.1556 0.1755 (17.91%) Market Cap: 3.77 Mil Enterprise Value: 981,000.00 PE Ratio: 0 PB Ratio: 1.01 GF Score: 30/100

Q1 2021 Processa Pharmaceuticals Inc Earnings Call Transcript

May 13, 2021 / 09:30PM GMT
Release Date Price: $123.2 (-0.81%)
Operator

Greetings, and welcome to Processa Pharmaceuticals's first-quarter 2021 earnings conference call and corporate update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions)

As a reminder, this conference call is being recorded. I would now like to introduce Jim Stanker, Chief Financial Officer. Thank you, sir. You may begin.

Jim Stanker
Processa Pharmaceuticals, Inc. - CFO

Thank you, operator. With me on the call are Dr. David Young, our Chief Executive Officer; and Mike Floyd, our Chief Operating Officer. Before we begin, I'd like to remind everyone that a PowerPoint presentation will accompany Dr. Young's prepared remarks. To view the PowerPoint slides, please go to the earnings Press Release and click on the webcast link to follow along.

Now I'd like to begin the call by reading the Safe Harbor Statement. This statement is made pursuant to the Safe Harbor for forward-looking statements described in the Private Securities Litigation Reform

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot